Total medical devices industry venture financing deals worth $54.8m were announced in China in November 2022, led by $13.99m venture financing of Anyipu (Suzhou) Medical Technology, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 67.3% over the previous month of $167.46m and a drop of 81.9% when compared with the last 12-month average of $302.09m.
China held a 10.07% share of the global medical devices industry venture financing deal value that totalled $544.06m in November 2022.
In terms of venture financing deal activity, China recorded 24 deals during November 2022, marking an increase of 20.00% over the previous month and a drop of 14.29% over the 12-month average.
China medical devices industry venture financing deals in November 2022: Top deals
The top three medical devices industry venture financing deals accounted for 76.27% of the overall value during November 2022.
The combined value of the top three medical devices venture financing deals stood at $41.8m, against the overall value of $54.8m recorded for the month.
The top three medical devices industry venture financing deals of November 2022 tracked by GlobalData were:
1) Dunhang Capital, Fengrui Capital, Green River Investment, Junshan Private Equity Fund of Funds and Yuansheng venture capital management’s $13.99m venture financing deal with Anyipu (Suzhou) Medical Technology
2) The $13.94m venture financing of Henan Sinotech Biotechnology by China SDIC Gaoxin Industrial Investment, Gaochuang Investment Management, Henan Zhongyuan Lianchuang Fund and Zhejiang Puhua Capital
3) MingFeng Capital and Shanghai Shenghe Investment Management’s $13.84m venture financing deal with Jiangsu Chuangying Medical Device